These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35579515)

  • 1. Arrhythmogenic Right Ventricular Cardiomyopathy Prevalence and Arrhythmic Outcomes in At-Risk Family Members: A Systematic Review and Meta-Analysis.
    Sharma A; Bosman LP; Tichnell C; Nanavati J; Murray B; Nonyane BAS; Tandri H; Calkins H; James CA
    Circ Genom Precis Med; 2022 Jun; 15(3):e003530. PubMed ID: 35579515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis.
    Agbaedeng TA; Roberts KA; Colley L; Noubiap JJ; Oxborough D
    Europace; 2022 Oct; 24(10):1665-1674. PubMed ID: 35298614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy.
    Smedsrud MK; Chivulescu M; Forså MI; Castrini I; Aabel EW; Rootwelt-Norberg C; Bogsrud MP; Edvardsen T; Hasselberg NE; Früh A; Haugaa KH
    Eur Heart J; 2022 Dec; 43(45):4694-4703. PubMed ID: 36036653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Follow-Up of Pediatric-Onset Arrhythmogenic Right Ventricular Cardiomyopathy.
    Roudijk RW; Verheul L; Bosman LP; Bourfiss M; Breur JMPJ; Slieker MG; Blank AC; Dooijes D; van der Heijden JF; van den Heuvel F; Clur SA; Udink Ten Cate FEA; van den Berg MP; Wilde AAM; Asselbergs FW; Peter van Tintelen J; Te Riele ASJM
    JACC Clin Electrophysiol; 2022 Mar; 8(3):306-318. PubMed ID: 35331425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis.
    Bosman LP; Sammani A; James CA; Cadrin-Tourigny J; Calkins H; van Tintelen JP; Hauer RNW; Asselbergs FW; Te Riele ASJM
    Heart Rhythm; 2018 Jul; 15(7):1097-1107. PubMed ID: 29408436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancies, ventricular arrhythmias, and substrate progression in women with arrhythmogenic right ventricular cardiomyopathy in the Nordic ARVC Registry.
    Platonov PG; Castrini AI; Svensson A; Christiansen MK; Gilljam T; Bundgaard H; Madsen T; Heliö T; Christensen AH; Åström MA; Carlson J; Edvardsen T; Jensen HK; Haugaa KH; Svendsen JH
    Europace; 2020 Dec; 22(12):1873-1879. PubMed ID: 32681178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.
    Protonotarios A; Anastasakis A; Panagiotakos DB; Antoniades L; Syrris P; Vouliotis A; Stefanadis C; Tsatsopoulou A; McKenna WJ; Protonotarios N
    Europace; 2016 Apr; 18(4):610-6. PubMed ID: 25825460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator.
    Protonotarios A; Bariani R; Cappelletto C; Pavlou M; García-García A; Cipriani A; Protonotarios I; Rivas A; Wittenberg R; Graziosi M; Xylouri Z; Larrañaga-Moreira JM; de Luca A; Celeghin R; Pilichou K; Bakalakos A; Lopes LR; Savvatis K; Stolfo D; Dal Ferro M; Merlo M; Basso C; Freire JL; Rodriguez-Palomares JF; Kubo T; Ripoll-Vera T; Barriales-Villa R; Antoniades L; Mogensen J; Garcia-Pavia P; Wahbi K; Biagini E; Anastasakis A; Tsatsopoulou A; Zorio E; Gimeno JR; Garcia-Pinilla JM; Syrris P; Sinagra G; Bauce B; Elliott PM
    Eur Heart J; 2022 Aug; 43(32):3053-3067. PubMed ID: 35766183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
    Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
    Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and management of arrhythmogenic right ventricular cardiomyopathy.
    Alblaihed L; Kositz C; Brady WJ; Al-Salamah T; Mattu A
    Am J Emerg Med; 2023 Mar; 65():146-153. PubMed ID: 36638611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update.
    Azaouagh A; Churzidse S; Konorza T; Erbel R
    Clin Res Cardiol; 2011 May; 100(5):383-94. PubMed ID: 21360243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Prediction of Ventricular Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
    Carrick RT; Te Riele ASJM; Gasperetti A; Bosman L; Muller SA; Pendleton C; Tichnell C; Murray B; Yap SC; van den Berg MP; Wilde A; Zeppenfeld K; Hays A; Zimmerman SL; Tandri H; Cadrin-Tourigny J; van Tintelen P; Calkins H; James CA; Wu KC
    Circ Arrhythm Electrophysiol; 2022 Nov; 15(11):e011207. PubMed ID: 36315818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    te Riele AS; James CA; Groeneweg JA; Sawant AC; Kammers K; Murray B; Tichnell C; van der Heijden JF; Judge DP; Dooijes D; van Tintelen JP; Hauer RN; Calkins H; Tandri H
    Eur Heart J; 2016 Mar; 37(9):755-63. PubMed ID: 26314686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients.
    Wang W; Tichnell C; Murray BA; Agafonova J; Cadrin-Tourigny J; Chelko S; Tandri H; Calkins H; James CA
    Europace; 2020 Aug; 22(8):1270-1278. PubMed ID: 32572458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.
    Maupain C; Badenco N; Pousset F; Waintraub X; Duthoit G; Chastre T; Himbert C; Hébert JL; Frank R; Hidden-Lucet F; Gandjbakhch E
    JACC Clin Electrophysiol; 2018 Jun; 4(6):757-768. PubMed ID: 29929669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of genetic testing in the diagnosis and risk stratification of arrhythmogenic right ventricular cardiomyopathy.
    de Brouwer R; Bosman LP; Gripenstedt S; Wilde AAM; van den Berg MP; Peter van Tintelen J; de Boer RA; Te Riele ASJM;
    Heart Rhythm; 2022 Oct; 19(10):1659-1665. PubMed ID: 35688345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
    Mazzanti A; Ng K; Faragli A; Maragna R; Chiodaroli E; Orphanou N; Monteforte N; Memmi M; Gambelli P; Novelli V; Bloise R; Catalano O; Moro G; Tibollo V; Morini M; Bellazzi R; Napolitano C; Bagnardi V; Priori SG
    J Am Coll Cardiol; 2016 Dec; 68(23):2540-2550. PubMed ID: 27931611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenic Right Ventricular Cardiomyopathy: A Review of Living and Deceased Probands.
    Blusztein DI; Zentner D; Thompson T; Jayadeva P; Liang D; Wang R; Winship I; James PA; Trainer AH; Kalman JM; Vohra J
    Heart Lung Circ; 2019 Jul; 28(7):1034-1041. PubMed ID: 30126789
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Brun F; Gigli M; Graw SL; Judge DP; Merlo M; Murray B; Calkins H; Sinagra G; Taylor MR; Mestroni L; James CA
    J Med Genet; 2020 Apr; 57(4):254-257. PubMed ID: 31924696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of patients with Arrhythmogenic Right Ventricular Cardiomyopathy in the Nordic countries.
    Haugaa KH; Bundgaard H; Edvardsen T; Eschen O; Gilljam T; Hansen J; Jensen HK; Platonov PG; Svensson A; Svendsen JH
    Scand Cardiovasc J; 2015; 49(6):299-307. PubMed ID: 26395672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.